Intranasal delivery of interleukin-4 attenuates chronic cognitive deficits via beneficial microglial responses in experimental traumatic brain injury

J Cereb Blood Flow Metab. 2021 Nov;41(11):2870-2886. doi: 10.1177/0271678X211028680. Epub 2021 Jul 14.

Abstract

Traumatic brain injury (TBI) is commonly followed by long-term cognitive deficits that severely impact the quality of life in survivors. Recent studies suggest that microglial/macrophage (Mi/MΦ) polarization could have multidimensional impacts on post-TBI neurological outcomes. Here, we report that repetitive intranasal delivery of interleukin-4 (IL-4) nanoparticles for 4 weeks after controlled cortical impact improved hippocampus-dependent spatial and non-spatial cognitive functions in adult C57BL6 mice, as assessed by a battery of neurobehavioral tests for up to 5 weeks after TBI. IL-4-elicited enhancement of cognitive functions was associated with improvements in the integrity of the hippocampus at the functional (e.g., long-term potentiation) and structural levels (CA3 neuronal loss, diffusion tensor imaging of white matter tracts, etc.). Mechanistically, IL-4 increased the expression of PPARγ and arginase-1 within Mi/MΦ, thereby driving microglia toward a global inflammation-resolving phenotype. Notably, IL-4 failed to shift microglial phenotype after TBI in Mi/MΦ-specific PPARγ knockout (mKO) mice, indicating an obligatory role for PPARγ in IL-4-induced Mi/MΦ polarization. Accordingly, post-TBI treatment with IL-4 failed to improve hippocampal integrity or cognitive functions in PPARγ mKO mice. These results demonstrate that administration of exogenous IL-4 nanoparticles stimulates PPARγ-dependent beneficial Mi/MΦ responses, and improves hippocampal function after TBI.

Keywords: Cognitive function; DTI; PPARγ; long-term potentiation; microglia polarization.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Adjuvants, Immunologic / pharmacology
  • Administration, Intranasal
  • Animals
  • Brain Injuries, Traumatic / complications
  • Brain Injuries, Traumatic / pathology
  • Brain Injuries, Traumatic / psychology*
  • CA3 Region, Hippocampal / diagnostic imaging
  • CA3 Region, Hippocampal / metabolism
  • Cognition / drug effects
  • Cognitive Dysfunction / diagnosis
  • Cognitive Dysfunction / drug therapy*
  • Cognitive Dysfunction / etiology
  • Diffusion Tensor Imaging / methods
  • Disease Models, Animal
  • Hippocampus / drug effects
  • Hippocampus / physiology
  • Inflammation / complications
  • Inflammation / metabolism
  • Interleukin-4 / administration & dosage
  • Interleukin-4 / pharmacology*
  • Long-Term Potentiation / drug effects
  • Long-Term Potentiation / physiology
  • Macrophage Activation / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Microglia / drug effects
  • Microglia / metabolism
  • Microglia / pathology*
  • Nanoparticles / administration & dosage
  • PPAR gamma / drug effects*
  • PPAR gamma / metabolism
  • Phenotype
  • Quality of Life
  • White Matter / diagnostic imaging
  • White Matter / metabolism

Substances

  • Adjuvants, Immunologic
  • PPAR gamma
  • Interleukin-4